ProJenX is a clinical-stage biotechnology company with novel, targeted, brain-penetrant therapies to address neurodegenerative diseases, with an initial focus on ALS. ProJenX was created out of a long-term research collaboration between Project ALS and Columbia University to rapidly develop and commercialize its lead therapy candidate, prosetin, for people with ALS. At the heart of ProJenX’s discoveries is an innovative, patient-specific, cell-based discovery platform that can be leveraged for the creation of additional transformative neuroscience medicines.
Free account • No credit card • 5 profiles/day
The widely used ProJenX email format is {first_initial}{last}@projenx.com (e.g. jsmith@projenx.com), which is used 75.00% of the time.
| ProJenX Email Formats | Example Email Formats | Adoption |
|---|---|---|
| {first_initial}{last} | jsmith@projenx.com |
75.00%
|
| Other formats | — |
25%
|
Adoption = share of company emails using each format — not a verification or accuracy score.
Origami Therapeutics, Inc.
Biotechnology Research • 2-10 employees • San Diego, United States
IMMvention Therapeutix, Inc.
Biotechnology Research • 11-50 employees • Durham, United States
Reglagene
Biotechnology Research • 11-50 employees • Tucson, United States
Amytrx Therapeutics, Inc.
Biotechnology Research • 2-10 employees • Nashville, United States
Nobias Therapeutics
Pharmaceutical Manufacturing • 11-50 employees
Cairn Biosciences
Biotechnology Research • 2-10 employees • San Francisco, United States
What is ProJenX email format?
The widely used ProJenX email format is {first_initial}{last} (e.g. jsmith@projenx.com) with 75.00% adoption across the company.
What is ProJenX customer service number?
To contact ProJenX customer service number in your country click here to find.
Who are the decision makers in ProJenX?
The decision makers in ProJenX are Erin Fleming, Stan Abel, etc. Click to Find ProJenX decision makers emails.
